InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the detailed record of transactions filed by SCHAFFER DAVID, Director. Officer active across 1 companies, notably 4D Molecular Therapeutics Inc.. Cumulatively, 6 filings have been logged. Total volume traded: €1.7m. The latest transaction was filed on 20 October 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€307,82511,565 shares@ €26.61735.8% of flow
Common Stock
SEC:0001567619-21-018628·
€307,82511,565 shares@ €26.6170.064% mcap17.9% of flow
Common Stock
SEC:0001567619-21-018628:0·
€188,3467,806 shares@ €24.128421.9% of flow
Common Stock
SEC:0001567619-21-017751·
€188,3467,806 shares@ €24.12840.039% mcap10.9% of flow
Common Stock
SEC:0001567619-21-017751:0·
€364,26813,075 shares@ €27.859942.3% of flow
Common Stock
SEC:0001567619-21-017624·
€364,26813,075 shares@ €27.85990.076% mcap21.2% of flow
Common Stock
SEC:0001567619-21-017624:0·
6 of 6 declarations
About SCHAFFER DAVID
Susan Muriel Ganeshan is Chief Marketing Officer at Clearwater Analytics Holdings, Inc. She is responsible for the company's marketing strategy and communications. Her role is essential in enhancing brand presence and supporting growth initiatives.
